Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanqin Oral Liquid for Hand, Foot, and Mouth Disease
ChiCTR-IPR-16008174Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Shantou University Medical College
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Lanqin Oral Liquid (2 arms), sponsored by The Second Affiliated Hospital of Shantou University Medical College. Primary endpoints: Time to first disappearance of oral ulcers and vesicles on hand or foot within 10 days, Time to first normalization of temperature (fever clearance) and 1 more. Started Apr 2016; status: recruiting.
02
Drugs
Lanqin Oral Liquid
Beyond the preview
Go deeper on ChiCTR-IPR-16008174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008174.